Страницы

Thursday, May 5, 2016

Health security

‘A step to reversing death’: New trial hopes to revive brain-dead patients


© AFPA US biotech company has been given regulatory approval to recruit 20 patients with no brain fu“This represents the first trial of its kind and another step towards the eventual reversal of death in our lifetime,” said Ira Pastor, the chief executive of Philadelphia-based Bioquark Inc.
The start-up was given the go-ahead for the Phase 1 trial by the US National Institutes of Health, but the study will go ahead at the Anupam Hospital in Rudrapur, in northern India, with support from prominent local researchers.
“We just received approval for our first 20 subjects and we hope to start recruiting patients immediately from this first site – we are working with the hospital now to identify families where there may be a religious or medical barrier to organ donation,” Pastor said.
The selected subjects have lost function of their brain stem, meaning they can no longer breathe or attain consciousness, and have to be kept alive artificially, although they maintain a range of automatic bodily functions, which allows them to survive, and even grow.nction and treat them with stem cells and lasers that researchers say could return them to life.

No comments:

Post a Comment